Apixaban and Appendicitis - a phase IV clinical study of FDA data

Summary:

Appendicitis is reported as a side effect among people who take Apixaban (apixaban), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Appendicitis when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Appendicitis?

Appendicitis (inflammation of the appendix) is found to be associated with 832 drugs and 899 conditions by eHealthMe. Check the latest studies of Appendicitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

60,044 people reported to have side effects when taking Apixaban.
Among them, 11 people (0.02%) have Appendicitis.

Among these 11 people:

How long have people been on Apixaban when they have Appendicitis? *

What is the gender of people who have Appendicitis when taking Apixaban? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Appendicitis when taking Apixaban? *

What are other drugs people take besides Apixaban? *

What are other side effects people have besides Appendicitis? *

Weakness: 1 person, 9.09%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 9.09%
Headache (pain in head): 1 person, 9.09%
Haematuria (presence of blood in urine): 1 person, 9.09%
Haematochezia (passage of stools containing blood): 1 person, 9.09%
Fatigue (feeling of tiredness): 1 person, 9.09%
Eye Pain: 1 person, 9.09%
Eye Haemorrhage (bleeding in the eye): 1 person, 9.09%
Chest Pain: 1 person, 9.09%
Catheter Site Infection (infection at the site of insertion): 1 person, 9.09%

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 36.36%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 9.09%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Colon Cancer: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Appendicitis?

- Check whether Appendicitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,351 reports)

Appendicitis treatments and more:

Appendicitis (11,953 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appendicitis:

Appendicitis (832 drugs)

Browse all the conditions that are associated with Appendicitis:

Appendicitis (899 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.